Platon Tzouvalis MSc
President

Mr. Tzouvalis, 42, was appointed President of Acrongenomics, Inc. on October 5th, 2006. As a Biochemist and ex-Abbott Laboratories Associate, he is an experienced pharmaceutical industry professional. He has been a member of Acrongenomics' Scientific Advisory Board since May 2004, and member of the Board of Directors as Vice President since February 14th, 2006. His expertise lies in the areas of Quality Control, Operational Procedures as well as Pharmaceutical Product and Process Improvement. He received his B.Sc. Degree in Biochemistry from the University of Illinois in 1990 and his Master's Degree in the same field from DePaul University at Chicago in 1995. Mr. Tzouvalis' earlier career includes working as a Research Chemist in collaboration with the University of Illinois at Chicago, holding the position of Research and Development Chemist at SynQuest, Inc. and as Advanced Quality Assurance Specialist of Organic Operations and then Project Manager in Bioanalytical Quality Assurance for Abbott Laboratories. Mr. Tzouvalis has also been awarded with the Abbott Diagnostics Division Science Award of 2002 as part of the Organic Operation Remediation Team.

 

Ron Lizee B.Comm. CGA. CFP
Chief Financial Officer

Mr. Lizee, 52, was appointed Chief Financial Officer of Acrongenomics in 2004. Mr. Lizee has over 25 years experience in the fields of tax, accounting and auditing.

 

Manos Topoglidis PhD
Chief Technology Officer

Dr. Topoglidis, 32, was appointed to the Board of Directors and Scientific Advisory Board on February 24, 2006 as Chief Technology Officer. He received his Bachelor's of Science from King's College (University of London) in 1996, his MSc in Biochemistry from Imperial College London in 1997 and his Ph.D. in Chemistry (Biosensors and Nanomaterials) from Imperial College London in 2001. His research interests and expertise lie in the areas of Biosensors, Nanomaterials, Biotechnology and Nanotechnology. He has worked as a research fellow at the Center of Electronic Materials and Devices of Imperial College London and as manager of European and National programs at the MESL laboratory of the National Centre for Scientific Research, Demokritos in Athens. He is a member of the Electrochemical and British Biochemical Societies. Dr. Topoglidis has impressive experience leading international research teams in academia to unlock nanotechnology solutions. He ranks among the first to extensively research the use of nanoporous surfaces for biosensing applications and has written numerous original nanotechnology-related publications, which have been cited worldwide.

 

Dr. Evan Manolis
Director

Dr. Evan Manolis received his B.S. from University of Illinois at Chicago in 1987 and his M.D. in surgery from Southern Illinois University Medical School in 1991. He received extensive postgraduate training in general surgery internship and residency from the Medical College in Ohio. Dr. Manolis practices plastic surgery in Chicago and Orland Park, Illinois and has been in the profession for 16 years.